L
LRMR
Larimar Therapeutics Inc
3.170
-0.120-3.65%After Hours: 3.130 -0.040 -1.26%18:59 06/05 EDT
OPEN/PREV CLOSE3.170/3.100
TODAY RANGE3.125-3.510
VOL8
MARKET CAP363.59M
52 WEEK RANGE2.220-6.42
AVG VOL (3M)1.74M
% TURNOVER2.95%
TURNOVER0
P/E (TTM)-1.6825
% RANGE12.42%
EPS(TTM)-2.0803
P/E(FORWARD)-2.1721
P/B2.301
BVPS1.521
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP351.87M
SHARES OUTSTANDING103.88M
NEXT EARNINGS08/12-08/17
FREE FLOAT100.53M
LOT SIZE1
EX-DATE05/29/2020
News
Press Releases
Financial Reports
Profile
TipRanks·05/30 09:01
Lamb Weston, FedEx, BioNTech, Zscaler, Larimar Trending With Analysts
Dow Jones·05/27 13:58
Larimar Therapeutics Initiated at Overweight by JP Morgan
Dow Jones·05/27 13:58
Larimar Therapeutics Price Target Announced at $9.00/Share by JP Morgan
TipRanks·05/27 09:15
Larimar Therapeutics initiated with an Overweight at JPMorgan
Reuters·05/27 08:06
U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys
TipRanks·05/19 21:14
Larimar Shareholders Approve Governance and Capital Structure Changes
Benzinga·05/18 13:15
Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Monday
Dow Jones·05/18 12:40
Larimar Therapeutics Price Target Cut to $12.00/Share From $13.00 by Wedbush
Dow Jones·05/18 12:40
Larimar Therapeutics Is Maintained at Outperform by Wedbush
Benzinga·05/18 12:30
Wedbush Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $12
TipRanks·05/18 11:55
Larimar Therapeutics price target lowered to $12 from $13 at Wedbush
Same Industry
Name/Symbol
Change%
Price